Healthy Clinical Trial
Official title:
Targeting Top-down and Bottom-up Processing in Eating Disorders Using Computerized Training Approaches: A Multimodal Outcome Study
This research project aims to explore the effectiveness of combined go/no-go training and
implementation intentions in targeting binge eating frequency among people with binge eating
disorder and bulimia nervosa.
The full intervention is 4 weeks long and consists of completing the training and food
diaries every day and meeting with the researcher twice for EEG recording. Moreover, it
involves completing questionnaires at baseline, at intervention completion, and one month
after the intervention.
Moreover, healthy control participants will be recruitment to complete baseline
questionnaires and take part in one EEG recording session in order to assess baseline
differences in brain activation in response to computer tasks.
Participants will learn about the study through flyers, e-mail, and social media (i.e.
twitter and Facebook) which will describe the interventional nature of the study, the main
eligibility criteria, and the researcher's contact information. Interested individuals will
be asked to contact the researchers, who will then send an information sheet detailing the
study procedure and what participation would involve. After reading the information sheet,
interested individuals will be contacted by the researchers in order to confirm all
eligibility criteria including diagnostic assessment. If these are met a PDF of the consent
form will be sent to the participants, including information about their rights as
participants and their ability to withdraw at any time without having to give a reason.
Participants who sign the consent form will respond to the email with the attached document.
Next, researchers will contact the participant to set an appointment to enter the lab for the
first EEG recording. Before entering the lab, participants will be asked to complete a food
diary and complete the complete a battery of questionnaires. The questionnaires include: 1) a
demographic questionnaire, 2) eating disorders examination questionnaire, 3) food ratings
test, 4) self-regulation of eating behaviour questionnaire for adults, 5) The negative
urgency scale, 6) the adults eating behaviour questionnaire, 7) GAD-7, and 8) PHQ-9.
Upon participants' arrival to the lab, participants will be asked to complete the food rating
task. Next, they will learn to complete the training tasks (i.e. food specific go/no-go and
general go/no-go) and perform them during EEG recording. They will be offered the opportunity
to ask questions relating to the task or the EEG at any time. Their weight will also be
measured.
Participants will be asked to complete the training and complete food diaries every day for
four weeks. The successful/ unsuccessful attempts at implementation intentions will be
assessed weekly by a mentor. A researcher/clinician will discuss setting the implementation
intention goals with the participant over email. At the end of the training, participants
will enter the lab to re-complete the four tasks while researchers record brain activation
using the EEG. They will also be asked to complete the food rating task again and their
weight will be re-assessed. Before leaving, they will be asked to complete a feedback sheet
in which they can express their experience with the training, in terms of facilitators and
barriers and visual analogue scales that will ask participants to rate the acceptability,
usefulness and level of burden experienced with training.
Participants will then be followed up at 1 month post-intervention; they will be asked to
complete the battery of questionnaires used at baseline and post-intervention.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |